Skip to main content
Top
Published in: Translational Neurodegeneration 1/2018

Open Access 01-12-2018 | Research

RETRACTED ARTICLE: Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease

Authors: Haichen Niu, Lingyu Shen, Tongzhou Li, Chao Ren, Sheng Ding, Lei Wang, Zhonghai Zhang, Xiaoyu Liu, Qiang Zhang, Deqin Geng, Xiujuan Wu, Haiying Li

Published in: Translational Neurodegeneration | Issue 1/2018

Login to get access

Abstract

Background

Parkinson’s disease (PD) is a neurodegenerative disease characterized by intraneuronal Lewy Body (LB) aggregates composed of misfolded alpha-synuclein (α-syn). The spread of misfolded α-syn follows a typical pattern: starting in the olfactory bulb (OB) and the gut, this pathology is followed by the progressive invasion of misfolded α-syn to the posterior part of the brain. It is unknown whether the administration of human mutant alpha-synuclein (hm-α-syn, a human mutation which occurs in familial PD) into the OB of rats would trigger similar α-syn propagation and subsequently cause pathological changes in broader brain fields associated to PD and establish an animal model of prodromal PD.

Methods

hm-α-syn was overexpressed in the OB of rats with an AAV injection. Then motor and non-motor symptoms of the SD rats were tested in different behavioral tasks following the AAV injection. In follow-up studies, pathological mechanisms of α-syn spread were explored at the histological, biochemical and micro-structure levels.

Results

The experimental results indicated that hm-α-syn was overexpressed in the OB 3 weeks after the AAV injection. 1) overexpression of the Hm-α-syn in the OB by the AAV injection could transfer to wider adjacent fields beyond the monosynaptic scope. 2) The number of tyrosine hydroxylase positive cells body and fibers was decreased in the substantia nigra (SN) 12 weeks after AAV injection. This was consistent with decreased levels of the DA neurotransmitter. Importantly, behavioral dysfunctions were found that included olfactory impairment after 3 weeks, motor ability impairment and decreased muscular coordination on a rotarod 6 weeks after the AAV injection.3) The morphological level studies found that the Golgi staining revealed the number of neuronal branches and synapses in the OB, prefrontal cortex (PFC), hippocampus (Hip) and striatum caudate putamen (CPU) were decreased. 4) phosphorylated α-syn, at Ser-129 (pSer129), was found to be increased in hm-α-syn injected animals in comparison to controls that overexpressed GFP alone, which was also found in the most of LB stained by the thioflavine S (ThS) in the SN field. 5) A marker of autophagy (LC3B) was increased in serval fields, which was colacolizated with a marker of apoptosis in the SN field.

Conclusions

These results demonstrate that expression of exogenous mutant α-syn in the OB induces pathological changes in the sensitive brain fields by transferring pathogenic α-syn to adjacent fields. This method may be useful for establishing an animal model of prodromal PD.
Literature
1.
2.
go back to reference Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB. AAV1/2-induced overexpression of A53T-alpha-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease. Acta Neuropathol Commun. 2017;5(1):11.PubMedPubMedCentralCrossRef Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB. AAV1/2-induced overexpression of A53T-alpha-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease. Acta Neuropathol Commun. 2017;5(1):11.PubMedPubMedCentralCrossRef
4.
go back to reference Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol. 2004;56(4):532–9.PubMedCrossRef Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol. 2004;56(4):532–9.PubMedCrossRef
5.
go back to reference Cao M, Gu ZQ, Li Y, Zhang H, Dan XJ, Cen SS, Li DW, Chan P. Olfactory dysfunction in Parkinson's disease patients with the LRRK2 G2385R variant. Neurosci Bull. 2016;32(6):572–6.PubMedPubMedCentralCrossRef Cao M, Gu ZQ, Li Y, Zhang H, Dan XJ, Cen SS, Li DW, Chan P. Olfactory dysfunction in Parkinson's disease patients with the LRRK2 G2385R variant. Neurosci Bull. 2016;32(6):572–6.PubMedPubMedCentralCrossRef
6.
go back to reference Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, et al. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism Relat Disord. 2016;25:45–51.PubMedPubMedCentralCrossRef Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, et al. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism Relat Disord. 2016;25:45–51.PubMedPubMedCentralCrossRef
7.
go back to reference Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T. The precursor protein of non-a beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14(2):467–75.PubMedCrossRef Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T. The precursor protein of non-a beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14(2):467–75.PubMedCrossRef
8.
go back to reference Bartels T, Choi JG, Selkoe DJ. Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477(7362):107–10.PubMedPubMedCentralCrossRef Bartels T, Choi JG, Selkoe DJ. Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477(7362):107–10.PubMedPubMedCentralCrossRef
9.
go back to reference Beyer K, Ariza A. alpha-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Mol Neurobiol. 2013;47(2):509–24.PubMedCrossRef Beyer K, Ariza A. alpha-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration. Mol Neurobiol. 2013;47(2):509–24.PubMedCrossRef
10.
go back to reference Longo F, Mercatelli D, Novello S, Arcuri L, Brugnoli A, Vincenzi F, Russo I, Berti G, Mabrouk OS, Kennedy RT, et al. Age-dependent dopamine transporter dysfunction and Serine129 phospho-alpha-synuclein overload in G2019S LRRK2 mice. Acta Neuropathol Commun. 2017;5(1):22.PubMedPubMedCentralCrossRef Longo F, Mercatelli D, Novello S, Arcuri L, Brugnoli A, Vincenzi F, Russo I, Berti G, Mabrouk OS, Kennedy RT, et al. Age-dependent dopamine transporter dysfunction and Serine129 phospho-alpha-synuclein overload in G2019S LRRK2 mice. Acta Neuropathol Commun. 2017;5(1):22.PubMedPubMedCentralCrossRef
11.
go back to reference Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160–4.PubMedCrossRef Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160–4.PubMedCrossRef
12.
go back to reference Samuel F, Flavin WP, Iqbal S, Pacelli C, Sri Renganathan SD, Trudeau LE, Campbell EM, Fraser PE, Tandon A. Effects of serine 129 phosphorylation on alpha-Synuclein aggregation, membrane association, and internalization. J Biol Chem. 2016;291(9):4374–85.PubMedCrossRef Samuel F, Flavin WP, Iqbal S, Pacelli C, Sri Renganathan SD, Trudeau LE, Campbell EM, Fraser PE, Tandon A. Effects of serine 129 phosphorylation on alpha-Synuclein aggregation, membrane association, and internalization. J Biol Chem. 2016;291(9):4374–85.PubMedCrossRef
13.
go back to reference Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34(4):521–33.PubMedCrossRef Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34(4):521–33.PubMedCrossRef
14.
go back to reference Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Neurobiol Dis. 2005;18(3):492–8.PubMedCrossRef Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease. Neurobiol Dis. 2005;18(3):492–8.PubMedCrossRef
15.
go back to reference Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, Muller A, et al. Inhibition of amyloid-beta plaque formation by alpha-synuclein. Nat Med. 2015;21(7):802–7.PubMedCrossRef Bachhuber T, Katzmarski N, McCarter JF, Loreth D, Tahirovic S, Kamp F, Abou-Ajram C, Nuscher B, Serrano-Pozo A, Muller A, et al. Inhibition of amyloid-beta plaque formation by alpha-synuclein. Nat Med. 2015;21(7):802–7.PubMedCrossRef
16.
go back to reference Lindstrom V, Fagerqvist T, Nordstrom E, Eriksson F, Lord A, Tucker S, Andersson J, Johannesson M, Schell H, Kahle PJ, et al. Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice. Neurobiol Dis. 2014;69:134–43.PubMedCrossRef Lindstrom V, Fagerqvist T, Nordstrom E, Eriksson F, Lord A, Tucker S, Andersson J, Johannesson M, Schell H, Kahle PJ, et al. Immunotherapy targeting alpha-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] alpha-synuclein mice. Neurobiol Dis. 2014;69:134–43.PubMedCrossRef
17.
go back to reference Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197–211.PubMedCrossRef Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197–211.PubMedCrossRef
20.
go back to reference Ninkina N, Connor-Robson N, Ustyugov AA, Tarasova TV, Shelkovnikova TA, Buchman VL. A novel resource for studying function and dysfunction of alpha-synuclein: mouse lines for modulation of endogenous Snca gene expression. Sci Rep. 2015;5:16615.PubMedPubMedCentralCrossRef Ninkina N, Connor-Robson N, Ustyugov AA, Tarasova TV, Shelkovnikova TA, Buchman VL. A novel resource for studying function and dysfunction of alpha-synuclein: mouse lines for modulation of endogenous Snca gene expression. Sci Rep. 2015;5:16615.PubMedPubMedCentralCrossRef
21.
go back to reference Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949–53.PubMedPubMedCentralCrossRef Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949–53.PubMedPubMedCentralCrossRef
22.
go back to reference Jones DR, Delenclos M, Baine AT, DeTure M, Murray ME, Dickson DW, McLean PJ. Transmission of soluble and insoluble alpha-Synuclein to mice. J Neuropathol Exp Neurol. 2015;74(12):1158–69.PubMed Jones DR, Delenclos M, Baine AT, DeTure M, Murray ME, Dickson DW, McLean PJ. Transmission of soluble and insoluble alpha-Synuclein to mice. J Neuropathol Exp Neurol. 2015;74(12):1158–69.PubMed
23.
go back to reference Mahul-Mellier AL, Vercruysse F, Maco B, Ait-Bouziad N, De Roo M, Muller D, Lashuel HA. Fibril growth and seeding capacity play key roles in alpha-synuclein-mediated apoptotic cell death. Cell Death Differ. 2015;22(12):2107–22.PubMedPubMedCentralCrossRef Mahul-Mellier AL, Vercruysse F, Maco B, Ait-Bouziad N, De Roo M, Muller D, Lashuel HA. Fibril growth and seeding capacity play key roles in alpha-synuclein-mediated apoptotic cell death. Cell Death Differ. 2015;22(12):2107–22.PubMedPubMedCentralCrossRef
24.
go back to reference Nielsen SB, Macchi F, Raccosta S, Langkilde AE, Giehm L, Kyrsting A, Svane AS, Manno M, Christiansen G, Nielsen NC, et al. Wildtype and A30P mutant alpha-synuclein form different fibril structures. PLoS One. 2013;8(7):e67713.PubMedPubMedCentralCrossRef Nielsen SB, Macchi F, Raccosta S, Langkilde AE, Giehm L, Kyrsting A, Svane AS, Manno M, Christiansen G, Nielsen NC, et al. Wildtype and A30P mutant alpha-synuclein form different fibril structures. PLoS One. 2013;8(7):e67713.PubMedPubMedCentralCrossRef
25.
go back to reference Rey NL, Petit GH, Bousset L, Melki R, Brundin P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 2013;126(4):555–73.PubMedPubMedCentralCrossRef Rey NL, Petit GH, Bousset L, Melki R, Brundin P. Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 2013;126(4):555–73.PubMedPubMedCentralCrossRef
26.
go back to reference Mason DM, Nouraei N, Pant DB, Miner KM, Hutchison DF, Luk KC, Stolz JF, Leak RK. Transmission of alpha-synucleinopathy from olfactory structures deep into the temporal lobe. Mol Neurodegener. 2016;11(1):49.PubMedPubMedCentralCrossRef Mason DM, Nouraei N, Pant DB, Miner KM, Hutchison DF, Luk KC, Stolz JF, Leak RK. Transmission of alpha-synucleinopathy from olfactory structures deep into the temporal lobe. Mol Neurodegener. 2016;11(1):49.PubMedPubMedCentralCrossRef
27.
go back to reference Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. Eur J Radiol. 2014;83(3):564–70.PubMedCrossRef Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. Eur J Radiol. 2014;83(3):564–70.PubMedCrossRef
28.
go back to reference Wolz M, Hahner A, Meixner L, Lohle M, Reichmann H, Hummel T, Storch A. Accurate detection of Parkinson's disease in tremor syndromes using olfactory testing. Eur Neurol. 2014;72(1–2):1–6.PubMedCrossRef Wolz M, Hahner A, Meixner L, Lohle M, Reichmann H, Hummel T, Storch A. Accurate detection of Parkinson's disease in tremor syndromes using olfactory testing. Eur Neurol. 2014;72(1–2):1–6.PubMedCrossRef
29.
go back to reference Chou KL, Bohnen NI. Performance on an Alzheimer-selective odor identification test in patients with Parkinson’s disease and its relationship with cerebral dopamine transporter activity. Parkinsonism Relat Disord. 2009;15(9):640–3.PubMedPubMedCentralCrossRef Chou KL, Bohnen NI. Performance on an Alzheimer-selective odor identification test in patients with Parkinson’s disease and its relationship with cerebral dopamine transporter activity. Parkinsonism Relat Disord. 2009;15(9):640–3.PubMedPubMedCentralCrossRef
30.
go back to reference Callaway EM. Transneuronal circuit tracing with neurotropic viruses. Curr Opin Neurobiol. 2008;18(6):617–23.PubMedCrossRef Callaway EM. Transneuronal circuit tracing with neurotropic viruses. Curr Opin Neurobiol. 2008;18(6):617–23.PubMedCrossRef
31.
go back to reference Kim EJ, Jacobs MW, Ito-Cole T, Callaway EM. Improved Monosynaptic Neural Circuit Tracing Using Engineered Rabies Virus Glycoproteins. Cell reports. 2016;15(4):692–699.PubMedCrossRef Kim EJ, Jacobs MW, Ito-Cole T, Callaway EM. Improved Monosynaptic Neural Circuit Tracing Using Engineered Rabies Virus Glycoproteins. Cell reports. 2016;15(4):692–699.PubMedCrossRef
32.
go back to reference Qi D, Zhang Q, Zhou W, Zhao J, Zhang B, Sha Y, Pang Z. Quantification of dopamine in brain microdialysates with high-performance liquid chromatography-tandem mass spectrometry. Anal Sci. 2016;32(4):419–24.PubMedCrossRef Qi D, Zhang Q, Zhou W, Zhao J, Zhang B, Sha Y, Pang Z. Quantification of dopamine in brain microdialysates with high-performance liquid chromatography-tandem mass spectrometry. Anal Sci. 2016;32(4):419–24.PubMedCrossRef
33.
go back to reference Li A, Gong L, Xu F. Brain-state-independent neural representation of peripheral stimulation in rat olfactory bulb. Proc Natl Acad Sci U S A. 2011;108(12):5087–92.PubMedPubMedCentralCrossRef Li A, Gong L, Xu F. Brain-state-independent neural representation of peripheral stimulation in rat olfactory bulb. Proc Natl Acad Sci U S A. 2011;108(12):5087–92.PubMedPubMedCentralCrossRef
34.
go back to reference Niu H, He X, Zhou T, Shi X, Zhang Q, Zhang Z, Qiao Y, Xu F, Hu M. Neural circuits containing olfactory neurons are involved in the prepulse inhibition of the startle reflex in rats. Front Behav Neurosci. 2015;9:74.PubMedPubMedCentralCrossRef Niu H, He X, Zhou T, Shi X, Zhang Q, Zhang Z, Qiao Y, Xu F, Hu M. Neural circuits containing olfactory neurons are involved in the prepulse inhibition of the startle reflex in rats. Front Behav Neurosci. 2015;9:74.PubMedPubMedCentralCrossRef
35.
go back to reference Schellinck HM, Rooney E, Brown RE. Odors of individuality of germfree mice are not discriminated by rats in a habituation-dishabituation procedure. Physiol Behav. 1995;57(5):1005–8.PubMedCrossRef Schellinck HM, Rooney E, Brown RE. Odors of individuality of germfree mice are not discriminated by rats in a habituation-dishabituation procedure. Physiol Behav. 1995;57(5):1005–8.PubMedCrossRef
36.
go back to reference Hamm RJ. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J Neurotrauma. 2001;18(11):1207–16.PubMedCrossRef Hamm RJ. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J Neurotrauma. 2001;18(11):1207–16.PubMedCrossRef
37.
go back to reference Soztutar E, Colak E, Ulupinar E. Gender- and anxiety level-dependent effects of perinatal stress exposure on medial prefrontal cortex. Exp Neurol. 2016;275(Pt 2):274–84.PubMedCrossRef Soztutar E, Colak E, Ulupinar E. Gender- and anxiety level-dependent effects of perinatal stress exposure on medial prefrontal cortex. Exp Neurol. 2016;275(Pt 2):274–84.PubMedCrossRef
38.
go back to reference Ranjan A, Mallick BN. Differential staining of glia and neurons by modified Golgi-cox method. J Neurosci Methods. 2012;209(2):269–79.PubMedCrossRef Ranjan A, Mallick BN. Differential staining of glia and neurons by modified Golgi-cox method. J Neurosci Methods. 2012;209(2):269–79.PubMedCrossRef
39.
go back to reference Pan B, Huang S, Sun S, Wang T. The neuroprotective effects of remifentanil on isoflurane-induced apoptosis in the neonatal rat brain. Am J Transl Res. 2017;9(10):4521–33.PubMedPubMedCentral Pan B, Huang S, Sun S, Wang T. The neuroprotective effects of remifentanil on isoflurane-induced apoptosis in the neonatal rat brain. Am J Transl Res. 2017;9(10):4521–33.PubMedPubMedCentral
40.
41.
go back to reference Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, Lee VM, Brundin P. Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease. J Exp Med. 2016;213(9):1759–78.PubMedPubMedCentralCrossRef Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, Lee VM, Brundin P. Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease. J Exp Med. 2016;213(9):1759–78.PubMedPubMedCentralCrossRef
42.
go back to reference Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol. 2003;62(6):644–54.PubMedCrossRef Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol. 2003;62(6):644–54.PubMedCrossRef
43.
go back to reference Deacon RM. Measuring motor coordination in mice. J Visualized Exp. 2013;75:e2609. Deacon RM. Measuring motor coordination in mice. J Visualized Exp. 2013;75:e2609.
44.
go back to reference Poehler AM, Xiang W, Spitzer P, May VE, Meixner H, Rockenstein E, Chutna O, Outeiro TF, Winkler J, Masliah E, et al. Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment. Autophagy. 2014;10(12):2171–92.PubMedCrossRef Poehler AM, Xiang W, Spitzer P, May VE, Meixner H, Rockenstein E, Chutna O, Outeiro TF, Winkler J, Masliah E, et al. Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment. Autophagy. 2014;10(12):2171–92.PubMedCrossRef
45.
go back to reference Berendse HW, Ponsen MM. Detection of preclinical Parkinson's disease along the olfactory trac(t). J Neural Transm Suppl. 2006;70:321–5. Berendse HW, Ponsen MM. Detection of preclinical Parkinson's disease along the olfactory trac(t). J Neural Transm Suppl. 2006;70:321–5.
47.
go back to reference Kim KH, Kang SY, Shin DA, Yi S, Ha Y, Kim KN, Sohn YH, Lee PH. Parkinson’s disease-related non-motor features as risk factors for post-operative delirium in spinal surgery. PLoS One. 2018;13(4):e0195749.PubMedPubMedCentralCrossRef Kim KH, Kang SY, Shin DA, Yi S, Ha Y, Kim KN, Sohn YH, Lee PH. Parkinson’s disease-related non-motor features as risk factors for post-operative delirium in spinal surgery. PLoS One. 2018;13(4):e0195749.PubMedPubMedCentralCrossRef
48.
go back to reference Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P. Non-motor symptoms of Parkinson's disease A review...from the past. J Neurol Sci. 2014;338(1–2):30–3.PubMedCrossRef Garcia-Ruiz PJ, Chaudhuri KR, Martinez-Martin P. Non-motor symptoms of Parkinson's disease A review...from the past. J Neurol Sci. 2014;338(1–2):30–3.PubMedCrossRef
49.
50.
go back to reference Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, de Leeuw FE, Pirtosek Z, Rektorova I, Schlesinger I, et al. An updated diagnostic approach to subtype definition of vascular parkinsonism - recommendations from an expert working group. Parkinsonism Relat Disord. 2017. Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, de Leeuw FE, Pirtosek Z, Rektorova I, Schlesinger I, et al. An updated diagnostic approach to subtype definition of vascular parkinsonism - recommendations from an expert working group. Parkinsonism Relat Disord. 2017.
51.
go back to reference Fengler S, Liepelt-Scarfone I, Brockmann K, Schaffer E, Berg D, Kalbe E. Cognitive changes in prodromal Parkinson's disease: a review. Mov Disord. 2017;32(12):1655–66.PubMedCrossRef Fengler S, Liepelt-Scarfone I, Brockmann K, Schaffer E, Berg D, Kalbe E. Cognitive changes in prodromal Parkinson's disease: a review. Mov Disord. 2017;32(12):1655–66.PubMedCrossRef
52.
go back to reference Kemp J, Philippi N, Phillipps C, Botzung A, Blanc F. Cognitive profile in prodromal disease (dementia) with Lewy bodies. Geriatr Psychol Neuropsychiatr Vieil. 2017;15(4):434–42.PubMed Kemp J, Philippi N, Phillipps C, Botzung A, Blanc F. Cognitive profile in prodromal disease (dementia) with Lewy bodies. Geriatr Psychol Neuropsychiatr Vieil. 2017;15(4):434–42.PubMed
53.
go back to reference Miners JS, Renfrew R, Swirski M, Love S. Accumulation of alpha-synuclein in dementia with Lewy bodies is associated with decline in the alpha-synuclein-degrading enzymes kallikrein-6 and calpain-1. Acta Neuropathol Commun. 2014;2:164.PubMedPubMedCentralCrossRef Miners JS, Renfrew R, Swirski M, Love S. Accumulation of alpha-synuclein in dementia with Lewy bodies is associated with decline in the alpha-synuclein-degrading enzymes kallikrein-6 and calpain-1. Acta Neuropathol Commun. 2014;2:164.PubMedPubMedCentralCrossRef
54.
go back to reference Magen I, Torres ER, Dinh D, Chung A, Masliah E, Chesselet MF. Social cognition impairments in mice overexpressing alpha-Synuclein under the Thy1 promoter, a model of pre-manifest Parkinson's disease. J Park Dis. 2015;5(3):669–80. Magen I, Torres ER, Dinh D, Chung A, Masliah E, Chesselet MF. Social cognition impairments in mice overexpressing alpha-Synuclein under the Thy1 promoter, a model of pre-manifest Parkinson's disease. J Park Dis. 2015;5(3):669–80.
55.
go back to reference Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, et al. Phosphorylated alpha-synuclein in Parkinson's disease. Sci Transl Med. 2012;4(121):121ra120. Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, et al. Phosphorylated alpha-synuclein in Parkinson's disease. Sci Transl Med. 2012;4(121):121ra120.
56.
go back to reference Paciotti S, Bellomo G, Gatticchi L, Parnetti L. Are we ready for detecting alpha-Synuclein prone to aggregation in patients? The case of “protein-Misfolding cyclic amplification” and “real-time quaking-induced conversion” as diagnostic tools. Front Neurol. 2018;9:415.PubMedPubMedCentralCrossRef Paciotti S, Bellomo G, Gatticchi L, Parnetti L. Are we ready for detecting alpha-Synuclein prone to aggregation in patients? The case of “protein-Misfolding cyclic amplification” and “real-time quaking-induced conversion” as diagnostic tools. Front Neurol. 2018;9:415.PubMedPubMedCentralCrossRef
57.
go back to reference Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011;69(3):570–80.PubMedPubMedCentralCrossRef Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011;69(3):570–80.PubMedPubMedCentralCrossRef
58.
go back to reference Ono K, Ikeda T, Takasaki J, Yamada M. Familial Parkinson disease mutations influence alpha-synuclein assembly. Neurobiol Dis. 2011;43(3):715–24.PubMedCrossRef Ono K, Ikeda T, Takasaki J, Yamada M. Familial Parkinson disease mutations influence alpha-synuclein assembly. Neurobiol Dis. 2011;43(3):715–24.PubMedCrossRef
59.
go back to reference Fares MB, Maco B, Oueslati A, Rockenstein E, Ninkina N, Buchman VL, Masliah E, Lashuel HA. Induction of de novo alpha-synuclein fibrillization in a neuronal model for Parkinson's disease. Proc Natl Acad Sci U S A. 2016;113(7):E912–21.PubMedPubMedCentralCrossRef Fares MB, Maco B, Oueslati A, Rockenstein E, Ninkina N, Buchman VL, Masliah E, Lashuel HA. Induction of de novo alpha-synuclein fibrillization in a neuronal model for Parkinson's disease. Proc Natl Acad Sci U S A. 2016;113(7):E912–21.PubMedPubMedCentralCrossRef
60.
go back to reference Miyamichi K, Amat F, Moussavi F, Wang C, Wickersham I, Wall NR, Taniguchi H, Tasic B, Huang ZJ, He Z, et al. Cortical representations of olfactory input by trans-synaptic tracing. Nature. 2011;472(7342):191–6.PubMedCrossRef Miyamichi K, Amat F, Moussavi F, Wang C, Wickersham I, Wall NR, Taniguchi H, Tasic B, Huang ZJ, He Z, et al. Cortical representations of olfactory input by trans-synaptic tracing. Nature. 2011;472(7342):191–6.PubMedCrossRef
61.
go back to reference Volpicelli-Daley LA, Luk KC, Lee VM. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc. 2014;9(9):2135–46.PubMedPubMedCentralCrossRef Volpicelli-Daley LA, Luk KC, Lee VM. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc. 2014;9(9):2135–46.PubMedPubMedCentralCrossRef
62.
go back to reference Visanji N, Marras C. The relevance of pre-motor symptoms in Parkinson's disease. Expert Rev Neurother. 2015;15(10):1205–17.PubMedCrossRef Visanji N, Marras C. The relevance of pre-motor symptoms in Parkinson's disease. Expert Rev Neurother. 2015;15(10):1205–17.PubMedCrossRef
63.
go back to reference Deems DA, Doty RL, Settle RG, Moore-Gillon V, Shaman P, Mester AF, Kimmelman CP, Brightman VJ, Snow JB Jr. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and taste center. Arch Otolaryngol Head Neck Surg. 1991;117(5):519–28.PubMedCrossRef Deems DA, Doty RL, Settle RG, Moore-Gillon V, Shaman P, Mester AF, Kimmelman CP, Brightman VJ, Snow JB Jr. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and taste center. Arch Otolaryngol Head Neck Surg. 1991;117(5):519–28.PubMedCrossRef
64.
go back to reference Liu J, Liu W, Lu Y, Tian H, Duan C, Lu L, Gao G, Wu X, Wang X, Yang H. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy. 2018;14(5):845–61.PubMedPubMedCentralCrossRef Liu J, Liu W, Lu Y, Tian H, Duan C, Lu L, Gao G, Wu X, Wang X, Yang H. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy. 2018;14(5):845–61.PubMedPubMedCentralCrossRef
65.
go back to reference Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49.PubMedCrossRef Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49.PubMedCrossRef
67.
go back to reference Larriva-Sahd J. Structural variation and interactions among astrocytes of the rostral migratory stream and olfactory bulb: II. Golgi and electron microscopic study of the adult rat. Neurosci Res. 2014;89:10–30.PubMedCrossRef Larriva-Sahd J. Structural variation and interactions among astrocytes of the rostral migratory stream and olfactory bulb: II. Golgi and electron microscopic study of the adult rat. Neurosci Res. 2014;89:10–30.PubMedCrossRef
68.
go back to reference Chen CC, Bajnath A, Brumberg JC. The impact of development and sensory deprivation on dendritic protrusions in the mouse barrel cortex. Cereb Cortex. 2015;25(6):1638–53.PubMedCrossRef Chen CC, Bajnath A, Brumberg JC. The impact of development and sensory deprivation on dendritic protrusions in the mouse barrel cortex. Cereb Cortex. 2015;25(6):1638–53.PubMedCrossRef
69.
go back to reference Ruan YW, Lei Z, Fan Y, Zou B, Xu ZC. Diversity and fluctuation of spine morphology in CA1 pyramidal neurons after transient global ischemia. J Neurosci Res. 2009;87(1):61–8.PubMedCrossRef Ruan YW, Lei Z, Fan Y, Zou B, Xu ZC. Diversity and fluctuation of spine morphology in CA1 pyramidal neurons after transient global ischemia. J Neurosci Res. 2009;87(1):61–8.PubMedCrossRef
Metadata
Title
RETRACTED ARTICLE: Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson’s disease
Authors
Haichen Niu
Lingyu Shen
Tongzhou Li
Chao Ren
Sheng Ding
Lei Wang
Zhonghai Zhang
Xiaoyu Liu
Qiang Zhang
Deqin Geng
Xiujuan Wu
Haiying Li
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2018
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/s40035-018-0128-6

Other articles of this Issue 1/2018

Translational Neurodegeneration 1/2018 Go to the issue